Alipogene Tiparvovec May Prevent Pancreatitis From Chylomicronaemia in Lipoprotein Lipase Deficiency (LPLD)

被引：0
|
作者：
Gaudet, D. [1 ]
Methot, J. [1 ]
Brisson, D. [1 ]
Dery, S. [1 ]
van den Bulk, N. [2 ]
Greentree, S. [2 ]
Gagne, C.
机构：
[1] Univ Montreal, Dept Med, Ecogene & Lipid Clin 21, Chicoutimi, PQ, Canada
[2] Amsterdam Mol Therapeut BV, Amsterdam, Netherlands
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 01期
关键词：
D O I：
10.1016/j.atherosclerosissup.2010.04.024
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
18
引用
收藏
页码：73 / 74
页数：4
相关论文
共 50 条
  • [1] Gene therapy with alipogene tiparvovec benefits lipoprotein lipase deficiency (LPLD) patients with pancreatitis history
    Greentree, S.
    Gaudet, D.
    Stroes, E.
    van den Bulk, N.
    de Wal, J.
    ATHEROSCLEROSIS, 2010, 213 (01) : E4 - E4
  • [2] ALIPOGENE TIPARVOVEC FOR THE TREATMENT OF LIPOPROTEIN LIPASE DEFICIENCY
    Haddley, K.
    DRUGS OF TODAY, 2013, 49 (03) : 161 - 170
  • [3] Alipogene tiparvovec: gene therapy for lipoprotein lipase deficiency
    Wierzbicki, Anthony S.
    Viljoen, Adie
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (01) : 7 - 10
  • [4] Alipogene Tiparvovec Gene Therapy Reduces the Risk of Acute Pancreatitis in Patients With Lipoprotein Lipase Deficiency
    Bruno, Marco J.
    Deakin, Mark
    Ruszniewski, Philippe B.
    Bulk, Nick V.
    de Wal, Janneke
    Camozzi, Carlos R.
    Gaudet, Daniel
    GASTROENTEROLOGY, 2012, 142 (05) : S112 - S112
  • [5] Alipogene Tiparvovec Gene Therapy Treatment of Lipoprotein Lipase Deficiency
    Davies, S.
    DRUGS OF THE FUTURE, 2008, 33 (12) : 1009 - 1011
  • [6] Alipogene tiparvovec reduces the risk of pancreatitis in lipoprotein lipase deficient patients
    de Wal, J.
    Methot, J.
    Dery, S.
    van den Bulk, N.
    Freidig, A.
    Greentree, S.
    Brisson, D.
    Gaudet, D.
    HUMAN GENE THERAPY, 2011, 22 (10) : A48 - A48
  • [7] RESULTS OF FIRST FOLLOW UP STUDY WITH GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD)
    Gaudet, D.
    De Wal, J.
    Brisson, D.
    van den Bulk, N.
    Greentree, S.
    Methot, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 15 - 15
  • [8] Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency
    Scott, Lesley J.
    DRUGS, 2015, 75 (02) : 175 - 182
  • [9] Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency
    Gaudet, Daniel
    de Wal, Janneke
    Tremblay, Karine
    Dery, Stephane
    van Deventer, Sander
    Freidig, Andreas
    Brisson, Diane
    Methot, Julie
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (01) : 55 - 60
  • [10] AAV1-LPLS447X Gene Therapy With Alipogene Tiparvovec Prevents Pancreatitis in Lipoprotein Lipase Deficiency
    Franssen, Remco
    Gaudet, Daniel
    Stroes, Erik S.
    Kastelein, John J.
    Brisson, Diane
    Rousseau, Sophie
    De Wal, Janneke
    Van Deventer, Sander J.
    CIRCULATION, 2009, 120 (18) : S591 - S592
12345